Cases & Deals

ConjuChem develops patent portfolio and participates in inter partes reexamination proceeding relating to therapeutic peptide conjugates

Clients ConjuChem Biotechnologies, Inc.

On behalf of ConjuChem Biotechnologies, Inc., Jones Day assisted with patent prosecution strategy and portfolio development relating to therapeutic peptide conjugates with prolonged half-lives. This work includes counseling and handling of an inter partes reexamination proceeding.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.